AM2201 7-hydroxyindole metabolite |
| カタログ番号GC40598 |
AM2201は、中枢カンナビノイド（CB1）受容体と末梢カンナビノイド（CB2）受容体のKi値がそれぞれ1.0nMと2.6nMである、強力な合成カンナビノイド（CB）です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1537889-11-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
AM2201 is a potent synthetic cannabinoid (CB) with Ki values of 1.0 and 2.6 nM for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. AM 2201 7-hydroxyindole metabolite is an expected minor monohydroxylated urinary metabolite of AM2201, based on the known metabolism of similar compounds. Its biological actions are unknown.
Average Rating: 5 (Based on Reviews and 29 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *